ישראל - עברית - Ministry of Health

rafa laboratories ltd - benzocaine 2 mg; tyrothricin 1 mg - lozenges - benzocaine - for the fast relief of severe sore throat. relief of mouth and throat infections.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - benzocaine 2 mg; tyrothricin 1 mg - lozenges - benzocaine - for the fast relief of severe sore throat. relief of mouth and throat infections.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - benzocaine 2 mg; tyrothricin 1 mg - lozenges - benzocaine - for the fast relief of severe sore throat. relief of mouth and throat infections.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - benzocaine 2 mg; tyrothricin 1 mg - lozenges - benzocaine - for the fast relief of severe sore throat. relief of mouth and throat infections.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - benzocaine 2 mg; tyrothricin 1 mg - lozenges - benzocaine - for the fast relief of severe sore throat. relief of mouth and throat infections.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - benzocaine 2 mg; tyrothricin 1 mg - lozenges - anesthetics, local - for the fast relief of severe sore throat. relief of mouth and throat infections.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - benzocaine 3.5 mg; tyrothricin 2 mg - lozenges - anesthetics, local - for the fast relief of severe sore throat . relief of mouth and throat infections.

ישראל - עברית - Ministry of Health

inspire md ltd - רופא - mguard prime coronary stent system is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • treatment of coronary lesion in patients undergoing primary or rescue pci for acute st-segment elevation myocardial infarction(stemi) • treatment of coronary lesion having atherothrombotic appearance in patients with non st-elevation acute coronary syndromes (unstable angina and non st-segment elevation myocardial infarction).

ישראל - עברית - Ministry of Health

ofek pharma ltd, israel - bupropion hydrochloride - טבליות עם שחרור נרחב - bupropion hydrochloride 150 mg - bupropion

ישראל - עברית - Ministry of Health

ofek pharma ltd, israel - bupropion hydrochloride - טבליות עם שחרור נרחב - bupropion hydrochloride 300 mg - bupropion